Spésifikasi fotuminum Aluminium: Mastikeun kasalametan, Épéktipasikeun, sareng patuh
Integritas produk farmasi penting pisan, jeung bungkusan muterkeun hiji peran kritis dina ngajaga kaamanan maranéhanana, épéktipasi, Sareng kahirupan.
Diantara rupa-rupa bahan bungkusan, pharmaceutical aluminium foil stands out for its exceptional barrier properties and versatility.
Sanajan kitu, not just any aluminium foil will suffice; stringent pharmaceutical aluminium foil specifications govern its composition, properties, and performance to meet the rigorous demands of the healthcare industry.
This article provides an in-depth exploration of these specifications, ensuring a comprehensive understanding for manufacturers, quality assurance professionals, and packaging engineers.

Aluminium foil is a cornerstone in pharmaceutical packaging due to its unique combination of characteristics.
It serves as an impermeable barrier, protecting sensitive drug formulations from degradation caused by external factors.
Pharmaceutical products are often susceptible to moisture, oksigén, cahayaan, mikroorganisme, sareng trasinant sanés.
Pharmaceutical aluminium foil effectively mitigates these risks. Its primary advantages include:
Consequently, understanding and adhering to precise pharmaceutical aluminium foil specifications is non-negotiable.
“Pharmaceutical grade” implies that the aluminium foil meets specific quality, purity, and performance standards suitable for direct or indirect contact with pharmaceutical products.
This designation is achieved through adherence to various pharmacopoeias, regulatory guidelines, and industry best practices.
These standards ensure that the foil itself does not contaminate the drug product or compromise its stability.

A comprehensive pharmaceutical aluminium foil specification encompasses several key parameters.
These parameters ensure the foil is fit for its intended purpose and complies with regulatory expectations.
The base material is a critical starting point.
The temper of the foil dictates its mechanical properties, such as hardness and ductility.
Thickness is a crucial parameter directly influencing barrier properties and mechanical strength.

The surface condition of the foil is vital for processing and final product appearance.
Bare aluminium foil is rarely used directly. Coatings and laminations are applied to impart specific functionalities crucial for pharmaceutical packaging.
Primers are applied to the aluminium foil surface to promote adhesion of subsequent layers like printing inks or heat-seal lacquers.
HSL is applied to the side of the foil that will be sealed to the blister base material (misalna., PVC, PVDC, PP, PET).

For branding, product identification, and regulatory information.
Applied over the printing to protect it from abrasion, kalembaban, or chemical attack.
In cold form (Alu-Alu) ulasan, the aluminium layer is laminated between an outer OPA (Oriented Polyamide/Nylon) layer and an inner PVC (or other polymer) lapis.
Beyond composition and coatings, specific performance metrics are essential.
This measures the pressure required to rupture the sealed foil, indicating the seal integrity and the force needed for push-through functionality.
It is a critical parameter for child-resistant and senior-friendly blister designs.

Pinholes are minute perforations in the foil that can compromise its barrier properties.
The ability of the foil to resist tearing, important for handling and for ensuring controlled opening of packages.
As mentioned under HSL, this is the force required to separate a sealed bond.
It must be strong enough to maintain a hermetic seal but allow for intended opening (misalna., push-liwat). This is measured in N/15mm or N/25mm.
Adherence to stringent regulatory and quality standards is fundamental for pharmaceutical aluminium foil specifications.
Relevant pharmacopoeias (misalna., USP ASp, Ep, J) may have specific monographs or general chapters pertaining to packaging materials, including aluminium foil, covering aspects like purity, extractable, and leachables.
In the U.S., materials intended for drug contact must comply with FDA regulations, such as those found in 21 CFR.
Suppliers often maintain Drug Master Files (DMFs) with the FDA, providing confidential detailed information about the foil and its components.
Similar regulations exist in the EU, governed by the European Medicines Agency (EMA) and specific directives/regulations concerning materials in contact with medicinal products (misalna., Regulation (EC) Henteu 1935/2004 for food contact materials, which is often referenced).
Suppliers of pharmaceutical aluminium foil must operate under GMP conditions to ensure consistent quality, tracakel, and prevention of contamination.
This includes controls over raw materials, Proses Produsensi, environment, personnel, and documentation.
For illustrative purposes, a simplified specification for a common blister lidding foil might include:
| Parameter | Spésifikasi | Test Method (Contona) |
|---|---|---|
| Base Foil Alloy | AA8011 | Chemical Analysis |
| Watekna | ‘O’ (Lemes, Diantared) | Hardness/Tensile Test |
| Ketebangan nominal | 25 µm | Micrometer (ASTM D374) |
| Toleransi Ketebalan | ± 5% | Micrometer |
| Primer Type | Vinyl Resin Based | FTIR / TDS |
| Primer Weight | 0.8 ± 0.3 g/m² | Gravimetric |
| Segel panas lacquer (HSL) | Vinyl Copolymer (misalna., for PVC sealing) | FTIR / TDS |
| HSL Weight | 4.0 – 7.0 g/m² | Gravimetric |
| Count pinhole | Max 1 per m² (dia. <50µm) | Lightbox (ASTM B479) |
| Kakuatan regangan (MD) | ≥ 50 N / mm² | ASTM E8 / Is 6892-1 |
| Elongasi (MD) | ≥ 5% | ASTM E8 / Is 6892-1 |
| Seal Strength to PVC | ≥ 7.5 N / 15mm (at specified sealing conditions) | ASTM F88 |
| Wettability (Print Side) | ≥ 38 dynes/cm | Dyne Test Pens |
| Residual Solvents | < 5 mg/m² total | Gas Chromatography |
| Microbial Limits | As per USP/EP requirements | USP ASp <61>, Ep 2.6.12 |
This table is illustrative; actual specifications are far more detailed and tailored to specific product needs and regulatory environments.
Choosing a supplier for pharmaceutical aluminium foil is a critical decision.
The pharmaceutical aluminium foil specification is not merely a document; it is a critical control strategy ensuring that the packaging reliably protects sensitive drug products throughout their lifecycle.
From the precise alloy composition and temper to the exact thickness, coating weights, and barrier performance, every detail matters.
Adherence to these comprehensive specifications, coupled with robust quality management systems and strong supplier partnerships, safeguards patient health by maintaining the intended quality, kasalametan, and efficacy of pharmaceutical formulations.
As drug products become more complex and sensitive, the role of high-quality, precisely specified aluminium foil will only continue to grow in importance.
A: AA8011 is a very common alloy for pharmaceutical blister lidding foil due to its good formability and strength after annealing. AA1235 is also used.
A: Temper dictates the foil’s mechanical properties.
Soft temper (‘O’) is crucial for lidding foils as it allows for good ductility for sealing over formed cavities and provides the necessary “push-liwat” ciri.
Suhu keras (‘H18’) offers higher strength and might be used for child-resistant features or more rigid structures.
A: Ideally, “pinhole-gratis” means no detectable perforations.
In practice, specifications often define an acceptable limit, such as less than 1 pinhole of a certain maximum diameter (misalna., <50µm) unggal méter pasagi, especially for the thinner gauges used in lidding.
For critical barrier applications like cold form foil, the expectation is effectively zero pinholes.
A: Seal strength is typically tested according to standards like ASTM F88 (“Standard Test Method for Seal Strength of Flexible Barrier Materials”).
A strip of the sealed material is pulled apart at a controlled rate, and the force required to separate the seal is measured.
A: A Drug Master File (DMF) is a confidential submission to regulatory authorities (like the FDA) by the foil manufacturer.
It contains detailed information about the chemistry, manufacturing, kontrol kualitas, and stability of the packaging material.
Pharmaceutical companies can then reference this DMF in their drug product applications, allowing the regulatory agency to review the packaging material information without the foil manufacturer disclosing proprietary details to the drug company.
© Hak Cipta © 2023 Huawei Phrma Foil Bungkusan
Ninggalkeun Balasan